The impact of regulations, tradition, and experimental design on clinical cancer trials: report and recommendations resulting from Washington Cancer Trials Conference.
Lasagna
L
L
Tufts Center for the Study of Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
Frei
E
E
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000379:methods; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004059:Diffusion of Innovation; D004219:District of Columbia; D017041:Ethics Committees; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents